ASCO GU 2023 Conference Coverage
Video Player is loading.
10 seconds
Playback speed
ASCO GU 2023 Outcomes by IMDC Risk in the COSMIC-313 Phase 3 Trial: Evaluating Cabozantinib + Nivo & Ipi in 1L Advanced RCC of IMDC Intermediate or Poor Risk
By
ASCO GU 2023 Conference Coverage
FEATURING
Thomas Powles
By
ASCO GU 2023 Conference Coverage
FEATURING
Thomas Powles
Comments 1
Login to view comments.
Click here to Login
